BRKM5 heads into today's earnings release on a remarkable surge — up 29% in a single session and 27% on the week — making this one of the most charged setups the Brazilian petrochemical giant has seen in years.
The price move is the story right now. The stock closed at BRL 11.87 on May 12, recovering sharply from levels below BRL 9.50 just a month ago. That 26% monthly gain is the kind of re-rating that compresses short interest in a hurry. The borrow market reflects the action: cost to borrow has climbed to 16.3%, more than 14 times its level from late 2024 when it barely exceeded 1%. That spike tells you lenders are demanding a premium to finance short positions — the lending market is pricing in genuine squeeze risk. Availability data is stale, so the precise depth of the borrow pool is unclear, but the CTB level alone signals a tighter-than-normal backdrop.
The analyst community is not chasing the rally. Eight analysts cover the stock, with seven holds and one outperform — a consensus that screams caution, not conviction. The mean price target sits at BRL 11.49, fractionally below where the stock is trading after yesterday's move. That gap matters: the Street's collective view was set before this week's surge, meaning the print either validates the re-rating or leaves the stock uncomfortably above a consensus that hasn't moved yet. EV/EBITDA sits at 9.3x, and the PE and PB multiples are both negative — flagging that Braskem remains in loss-making territory on a trailing basis. Bulls lean on the 82nd percentile ranking for 12-month forward EPS momentum, suggesting analysts do see earnings recovering ahead. Bears note the company has consistently underdelivered on near-term estimates, with 30-day EPS momentum ranking in just the 11th percentile.
The ownership picture is dominated by two Brazilian anchors. Kieppe Participações holds 38% of the company, and Petrobras owns 36% — leaving less than 26% in freely floating hands. Norges Bank trimmed its stake in early March. Vanguard and BlackRock both added modestly in recent months. That concentrated ownership structure limits liquidity and amplifies the impact of any institutional move in either direction. Past earnings reactions add important colour: the most recent prior print on March 27 saw the stock fall 11% on the day and 17% over the following five sessions — a punishing reaction. The two events in late April recovered better, with a 1-day gain of 8% and a 5-day gain of 11.5% on the most recent. The direction of single-day moves has been wildly inconsistent.
The print will test whether the dramatic rally this week reflects genuine fundamental improvement — a recovery in petrochemical spreads, progress on debt reduction, or a restructuring catalyst — or whether the stock has simply run ahead of what the numbers can support when the Street's hold-heavy consensus sits below the current price.
See the live data behind this article on ORTEX.
Open BRKM5 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
